Macozinone

DB14821InvestigationalSmall molecule

Macozinone is under investigation in clinical trial NCT03036163 (Phase 1 Study of PBTZ169).

Chemical structure of Macozinone
Formula / weight
C20H23F3N4O3S · 456.48 g/mol (avg)
Code names
PBTZ169

Resolves to

Compound
UNIIA3M1353L40CAS1377239-83-2ChEMBLCHEMBL3330226
Structure
InChIKeyBJDZBXGJNBMCAV-UHFFFAOYSA-NSMILES[O-][N+](=O)C1=C2SC(=NC(=O)C2=CC(=C1)C(F)(F)F)N1CCN(CC2CCCCC2)CC1

What you can answer from here — as of February 21, 2021

5Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Macozinone, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In